Answers are grounded in this paper and cite their sources.
Supports genetic testing for glycerol kinase deficiency in refractory hypertriglyceridemia with clear serum; leaves open its prevalence.
Pseudohypertriglyceridemia (pseudo-HTG) is a rare laboratory phenomenon in which serum triglyceride levels are falsely elevated due to analytical interference from endogenous glycerol, most often caused by glycerol kinase deficiency (GKD), an X-linked disorder caused by pathogenic variants in the GK gene. We report a 50-year-old man referred for persistent hypertriglyceridemia (4.98–7.42 mmol/L) over two years despite dietary modification and statin–fibrate therapy. He had no history of pancreatitis, alcohol intake, diabetes, renal or thyroid dysfunction. Physical examination showed no xanthomas or corneal arcus; body mass index was 26.9 kg/m2. Serum samples were repeatedly visually clear, and lipoprotein electrophoresis revealed an unexpectedly normal lipid distribution. Given the discordance between triglyceride concentrations and the clinical and electrophoretic findings, pseudo-HTG due to GKD was suspected. Glycerol-specific biochemical testing was locally unavailable. Thus, we performed whole genome sequencing (WGS), which identified a likely pathogenic GK nonsense variant, c.1324C>T (p.Gln442Ter), consistent with isolated GKD. Peripheral atherosclerosis and hepatic steatosis were also noted, indicating coexisting cardiometabolic disease. This case highlights isolated GKD as an underrecognized cause of prominent treatment-refractory HTG. In patients with discordant triglyceride results, clear fasting serum, and normal lipoprotein electrophoresis, pseudo-HTG should be considered; genetic evaluation may be informative when glycerol-specific assays are unavailable.
No takes yet. Share an insight, caveat, or question.
Ershova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: